Limited Liability Company (LLC)
Codeit4us RND
Codeit4us RND Spółka z Ograniczoną Odpowiedzialnością
Limited Liability Company (LLC)
Codeit4us RND Spółka z Ograniczoną Odpowiedzialnością
Codeit4us RND compared with its industry and competitors: revenue, profit and capital percentiles. Regional ranking and position within its PKD class.
Sector benchmark available (PKD 72.10.Z), no company financial data to compare.
Comparison with selected competing entities based on the most important financial indicators from recent years.
Type a name or KRS number to add any company to the chart and table below. Compared: 6 (5 competitors + analysed).
Indicator: Revenue
One chart shows the analysed company alongside selected competitors. The view presents the most important financial indicators from recent years, letting you quickly assess scale, profitability and the company's market position.
A side-by-side comparison of the most important financial data for the analysed company and its peers.
| Company | Revenue▼ | Net profit | EBITDA | Assets | Equity | Net margin | ROE | Liquidity | Years | Latest year | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Codeit4us RNDAnalysed WARSZAWA · Badania i rozwój | 607,0 tys. zł | 551,4 tys. zł | - | 646,9 tys. zł | 556,4 tys. zł | 90,85% | 99,10% | - | 1 | 2025 | |
PIT-RADWAR WARSZAWA · Badania i rozwój | 641,8 mln zł | 53,5 mln zł | 128,2 mln zł | 2,5 mld zł | 651,0 mln zł | 8,33% | 8,21% | 1,31 | 1 | 2024 | |
NOVO NORDISK PHARMA WARSZAWA · Badania i rozwój | 500,5 mln zł | 31,3 mln zł | 32,1 mln zł | 258,1 mln zł | 135,0 mln zł | 6,25% | 23,17% | 6,57 | 8 | 2025 | |
INSTYTUT ŁĄCZNOŚCI - PAŃSTWOWY INSTYTUT… WARSZAWA · Badania i rozwój | 222,6 mln zł | 12,4 mln zł | - | 104,6 mln zł | 31,1 mln zł | 5,56% | 39,78% | 11,70 | 4 | 2024 | |
PAREXEL POLSKA WARSZAWA · Badania i rozwój | 177,5 mln zł | 20,4 mln zł | - | 67,2 mln zł | 45,3 mln zł | 11,46% | 44,94% | 6,51 | 6 | 2024 | |
PSE INNOWACJE WARSZAWA · Badania i rozwój | 126,1 mln zł | 6,5 mln zł | 8,6 mln zł | 73,8 mln zł | 38,0 mln zł | 5,15% | 17,09% | 3,60 | 7 | 2025 |
Each row is a different financial indicator. The arrow and percentage value show how much each competitor exceeds or trails the analysed company.Green means the analysed company leads, red - that it falls behind.
| Indicator | Codeit4us RND 2025 | PIT-RADWAR 2024 | NOVO NORDISK PHARMA 2025 | INSTYTUT ŁĄCZNOŚCI - PAŃSTW… 2024 | PAREXEL POLSKA 2024 | PSE INNOWACJE 2025 |
|---|---|---|---|---|---|---|
| Revenue | 607,0 tys. zł | 641,8 mln zł +105636.8% | 500,5 mln zł +82353.1% | 222,6 mln zł +36576.5% | 177,5 mln zł +29145.3% | 126,1 mln zł +20679.1% |
| Net profit | 551,4 tys. zł | 53,5 mln zł +9596.5% | 31,3 mln zł +5572.5% | 12,4 mln zł +2145.5% | 20,4 mln zł +3590.8% | 6,5 mln zł +1077.3% |
| EBITDA | - | 128,2 mln zł | 32,1 mln zł | - | - | 8,6 mln zł |
| Operating profit | - | 83,0 mln zł | 30,9 mln zł | 12,4 mln zł | 5,9 mln zł | 7,8 mln zł |
| Assets | 646,9 tys. zł | 2,5 mld zł +380569.0% | 258,1 mln zł +39790.8% | 104,6 mln zł +16067.6% | 67,2 mln zł +10292.7% | 73,8 mln zł +11314.4% |
| Equity | 556,4 tys. zł | 651,0 mln zł +116899.1% | 135,0 mln zł +24164.5% | 31,1 mln zł +5493.9% | 45,3 mln zł +8038.5% | 38,0 mln zł +6725.8% |
| Net margin | 90,85% | 8,33% -82.5 pp | 6,25% -84.6 pp | 5,56% -85.3 pp | 11,46% -79.4 pp | 5,15% -85.7 pp |
| ROE | 99,10% | 8,21% -90.9 pp | 23,17% -75.9 pp | 39,78% -59.3 pp | 44,94% -54.2 pp | 17,09% -82.0 pp |
| Current ratio | - | 1,31 | 6,57 | 11,70 | 6,51 | 3,60 |
Peer entities are picked based on activity profile (PKD), voivodeship, business scale and data availability. You can add your own peers using the search above.
Filter: PKD 72.10.Z, voivodeship mazowieckie. Data taken from /ranking and /reports.
PKD 72.10.Z - MAZOWIECKIE
Voivodeship
MAZOWIECKIE
32 companies in PKD in this voivodeship
Companies in PKD - voivodeship
32
Companies in PKD - nationwide
80
Voivodeship share of PKD
40.00%
Revenue position
Rank 38 - broader population
Avg. PKD revenue (region)
1.7 M PLN
Median PKD revenue (region)
68.0 K PLN